Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JT002 nasal spray in adults with seasonal allergic rhinitis (Phase II)
CTR20250089Phase 2Completed
- Sponsor
- Jisheng Aoma
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JT002 in seasonal allergic rhinitis (SAR), sponsored by Jisheng Aoma. Started Jan 2025; status: completed.
02
Drugs
JT002
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on CTR20250089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250089.